Skip to content

Korsana Biosciences

US · KRSA #2830 by market cap Listed 1970
37.56 +2.11 +5.95%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Korsana Biosciences

Korsana Biosciences, Inc. is a biopharmaceutical company, which engages in discovering and developing novel therapies to reduce the burden of neurodegenerative diseases. Its portfolio includes the KRSA-028 pipeline. The company was founded in 2024 and is headquartered in Waltham, MA.

Founded
2024
CEO
Dr. Jonathan Violin, M.B.A.,PhD
Employees
19
Headquarters
Waltham, Massachusetts, United States of America
Fiscal year end
12-31
Website
korsana.com

Company profile

Exchange
US
Symbol
KRSA
Market-cap rank
#2830
Listing date
1970-01-01
Market cap
1.71B
Float cap
1.23B
Shares out
45.54M
Float shares
32.75M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Korsana Biosciences discussion 0 comments

Add a comment